Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.
Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J; Task Force. Galiè N, et al. Among authors: higenbottam t. Eur Heart J. 2004 Dec;25(24):2243-78. doi: 10.1016/j.ehj.2004.09.014. Eur Heart J. 2004. PMID: 15589643 No abstract available.
[Guidelines on diagnosis and treatment of pulmonary arterial hypertension].
Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G; Grupo de Trabajo sobre el diagnóstico y tratamiento de la Hipertensión Arterial Pulmonar de la Sociedad Europea de Cardiología. Galiè N, et al. Among authors: higenbottam t. Rev Esp Cardiol. 2005 May;58(5):523-66. doi: 10.1157/13074846. Rev Esp Cardiol. 2005. PMID: 15899198 Free article. Spanish. No abstract available.
Treatments for severe pulmonary hypertension.
Higenbottam T, Stenmark K, Simonneau G. Higenbottam T, et al. Lancet. 1999 Jan 30;353(9150):338-40. doi: 10.1016/S0140-6736(98)00330-4. Lancet. 1999. PMID: 9950432 Review. No abstract available.
Inhaled iloprost for severe pulmonary hypertension.
Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W; Aerosolized Iloprost Randomized Study Group. Olschewski H, et al. Among authors: higenbottam t. N Engl J Med. 2002 Aug 1;347(5):322-9. doi: 10.1056/NEJMoa020204. N Engl J Med. 2002. PMID: 12151469 Free article. Clinical Trial.
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.
Langleben D, Christman BW, Barst RJ, Dias VC, Galiè N, Higenbottam TW, Kneussl M, Korducki L, Naeije R, Riedel A, Simonneau G, Hirsch AM, Rich S, Robbins IM, Oudiz R, McGoon MD, Badesch DB, Levy RD, Mehta S, Seeger W, Solèr M. Langleben D, et al. Am Heart J. 2002 May;143(5):E4. doi: 10.1067/mhj.2002.121806. Am Heart J. 2002. PMID: 12040360 Clinical Trial.
Alpha-adrenoceptor stimulation of porcine pulmonary arteries.
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Ridden C, Kealey T. Pepke-Zaba J, et al. Among authors: higenbottam tw. Eur J Pharmacol. 1993 Apr 28;235(2-3):169-75. doi: 10.1016/0014-2999(93)90133-3. Eur J Pharmacol. 1993. PMID: 8389712
349 results